ACTAVIA LIFE SCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q2 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Actavia Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2015 to Q1 2024.
  • Actavia Life Sciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$71.4K, a 98.2% increase year-over-year.
  • Actavia Life Sciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$345K, a 91.9% increase year-over-year.
  • Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2023 was -$4.24M, a 3104% decline from 2022.
  • Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2022 was $141K.
  • Actavia Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$248K, a 95.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$345K -$71.4K +$3.9M +98.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$4.24M -$125K -$1.92K -1.56% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-16
Q3 2023 -$4.24M -$48.8K -$17.8K -57.5% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-05
Q2 2023 -$4.22M -$100K +$27.5K +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$4.25M -$3.97M -$4.35M -1139% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $100K -$123K -$41K -50.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-16
Q3 2022 $141K -$31K -$96.3K -147% Jul 1, 2022 Sep 30, 2022 10-K 2024-01-05
Q2 2022 $237K -$128K -$63.3K -98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $301K $382K +$475K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$175K -$81.8K +$73.2K +47.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-03-02
Q3 2021 -$248K $65.3K +$5.07M Jul 1, 2021 Sep 30, 2021 10-K 2023-02-09
Q2 2021 -$5.32M -$64.6K +$28K +30.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$5.35M -$93.6K +$88K +48.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-21
Q4 2020 -$5.43M -$155K -$5.66K -3.79% Oct 1, 2020 Dec 31, 2020 10-Q 2022-06-16
Q3 2020 -$5.43M -$5.01M -$4.94M -8145% Jul 1, 2020 Sep 30, 2020 10-K/A 2022-06-10
Q2 2020 -$484K -$92.6K +$99.3K +51.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$583K -$182K +$81.7K +31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-02
Q4 2019 -$665K -$149K +$250K +62.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-04-05
Q3 2019 -$915K -$60.7K +$61.4K +50.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-01-15
Q2 2019 -$977K -$192K +$618K +76.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$1.59M -$263K +$873K +76.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$2.47M -$399K +$1.6M +80% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$4.07M -$122K +$127K +50.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-01-13
Q2 2018 -$4.19M -$809K +$421K +34.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$4.62M -$1.14M -$147K -14.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$4.47M -$2M -$622K -45.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$3.85M -$249K +$1.59M +86.5% Jul 1, 2017 Sep 30, 2017 10-KT 2017-11-30
Q2 2017 -$5.44M -$1.23M -$901K -273% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$4.53M -$990K -$777K -365% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$3.76M -$1.38M -$1.24M -879% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 -$2.52M -$1.84M -$1.72M -1465% Jul 1, 2016 Sep 30, 2016 10-K 2017-06-29
Q2 2016 -$801K -$330K -$223K -208% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$578K -$213K Jan 1, 2016 Mar 31, 2016 10-K 2017-06-29
Q4 2015 -$141K Oct 1, 2015 Dec 31, 2015 10-K 2017-06-29
Q3 2015 -$117K Jul 1, 2015 Sep 30, 2015 10-K 2017-06-29
Q2 2015 -$107K Apr 1, 2015 Jun 30, 2015 10-K 2017-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.